Crespo Araico L A, Vera Lechuga R, Cruz-Culebras A, Matute Lozano C, de Felipe Mimbrera A, Agüero Rabes P, Viedma Guiard E, Estévez Fraga C, Masjuan Vallejo J
Servicio de Neurología, Hospital Universitario Ramón y Cajal, Departamento de Neurología, Facultad de Medicina, Universidad de Alcalá (IRYCIS), Madrid, España.
Servicio de Neurología, Hospital Universitario Ramón y Cajal, Departamento de Neurología, Facultad de Medicina, Universidad de Alcalá (IRYCIS), Madrid, España.
Neurologia (Engl Ed). 2019 Apr;34(3):153-158. doi: 10.1016/j.nrl.2016.11.005. Epub 2017 Jan 12.
Cervical artery dissection (CAD) is responsible for up to 20% of all ischaemic strokes in patients younger than 45. The benefits of acute-phase reperfusion therapy in these patients have yet to be confirmed.
We conducted a retrospective review of patients with CAD admitted to a comprehensive stroke centre between 2010 and 2015. We recorded baseline clinical characteristics, treatments, functional outcomes, and mortality.
We identified 35 cases of CAD (23 carotid/12 vertebral); mean age was 43.5 ± 9.5 years and 67.7% were men. Ten patients (32.3%) had a history of trauma. The most frequent risk factors were arterial hypertension (29%) and smoking (35.5%). The most common clinical presentation was ischaemic stroke (29 patients, 93.5%). The median baseline National Institute of Health Stroke Scale score was 6 (range, 0-41). The most frequently used diagnostic method was CT angiography (74.2%), followed by MRI (64.5%) and digital subtraction angiography (45.6%). Seven patients (22.6%) were treated with intravenous fibrinolysis and 11 (35.5%) with endovascular treatment plus intravenous fibrinolysis; at 3 months, functional independence (modified Rankin Scale scores 0-2) was achieved by 57.1% and 63.6% of these cases, respectively. One patient died (3.2%).
In our sample, the most common form of presentation of CAD was ischaemic stroke. Reperfusion therapy seems to be a safe and effective option for these patients, and outcomes resemble those of other patients with ischaemic stroke. Larger comparative studies are necessary to better assess response to reperfusion therapy in acute ischaemic stroke.
在45岁以下的患者中,颈内动脉夹层(CAD)导致的缺血性卒中占所有此类卒中的比例高达20%。急性期再灌注治疗对这些患者的益处尚未得到证实。
我们对2010年至2015年间入住综合性卒中中心的CAD患者进行了回顾性研究。我们记录了基线临床特征、治疗方法、功能转归和死亡率。
我们确定了35例CAD患者(23例颈动脉/12例椎动脉);平均年龄为43.5±9.5岁,67.7%为男性。10例患者(32.3%)有外伤史。最常见的危险因素是动脉高血压(29%)和吸烟(35.5%)。最常见的临床表现是缺血性卒中(29例患者,93.5%)。基线美国国立卫生研究院卒中量表评分的中位数为6(范围为0 - 41)。最常用的诊断方法是CT血管造影(74.2%),其次是MRI(64.5%)和数字减影血管造影(45.6%)。7例患者(22.6%)接受了静脉溶栓治疗,11例患者(35.5%)接受了血管内治疗加静脉溶栓治疗;在3个月时,这些病例中分别有57.1%和63.6%的患者实现了功能独立(改良Rankin量表评分0 - 2)。1例患者死亡(3.2%)。
在我们的样本中,CAD最常见的表现形式是缺血性卒中。再灌注治疗似乎是这些患者安全有效的选择,其转归与其他缺血性卒中患者相似。需要进行更大规模的对照研究,以更好地评估急性缺血性卒中患者对再灌注治疗的反应。